{
    "Disease activity (follow up: 6 months; assessed with: DAS28-ESR (Lower values â€“ > benefit) (MCID -1.17)": 
    {
      "No of studies": ["1", "3"],
      "Study design": "randomised trials",
      "Risk of bias": ["very serious", "a"],
      "Inconsistency": "not serious",
      "Indirectness": "not serious",
      "Imprecision": "not serious",
      "Other considerations": "none",
      "No of patients": {
        "MTX monotherapy": "147",
        "LEF": "147"
      },
      "Effect": {
        "Relative (95% CI)": "-",
        "Absolute (95% CI)": "MD 0.1 lower (0.27 lower to 0.07 higher)"
      },
      "Certainty": "LOW",
      "Importance": "CRITICAL"
    }
  }